GROOVE BOTANICALS INC. reported a net loss of $(358,387) for fiscal 2026, unchanged diluted EPS of $(0.01), and no revenue for both fiscal 2026 and 2025 as disclosed in its 10-K filing, leaving the company in a pre-revenue position with limited near-term commercial activity.
Financial Highlights
- Revenue was $0 for FY 2026 and $0 for FY 2025 (no product revenue reported).
- Net income was a loss of $(358,387) for FY 2026, compared with a loss of $(349,304) for FY 2025.
- Diluted EPS was $(0.01) for FY 2026, unchanged from $(0.01) for FY 2025.
Business Highlights
- Company remains pre-revenue and does not expect near-term product sales, underscoring limited commercial activity.
- Operating expenses rose modestly to $139,917 in FY 2026, driven by higher consulting and general & administrative costs; rent and professional fees were largely stable.
- Operations are run by a sole officer/director supported by outsourced third-party services to keep overhead low.
- Liquidity is constrained with cash of $1,502 and ongoing net losses, creating substantial doubt about the company's ability to continue as a going concern; management is pursuing a new business model and additional financing.
Original SEC Filing:
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.